InvestorsHub Logo

Battle Ready

12/16/22 7:35 PM

#21056 RE: Cyosol #21055

You just articulated the worst fear that any of us would have right now! Obviously, what you are suggesting is not crazy when it comes to how Silverman operates.

But, those two trials are not going to cost SNPX all that much money as the partners (Nemours DuPont and Cleveland Clinic) are largely incurring the expenses. The burn rate is relatively low and there is a lot of cash. For Silverman to orchestrate for the company to pay the preferred holders with dirt cheap stock rather than cash, has to, and I mean has to expose him to legal consequences!

The deal was absurd and completely unnecessary, if he wants to push it, we've got a lawsuit to slam him with!!!!

runncoach

12/16/22 9:35 PM

#21059 RE: Cyosol #21055

Wouldn't be my preference. Will be a long trudge.

XenaLives

12/18/22 12:08 AM

#21077 RE: Cyosol #21055

Preferred will repo the company and drug..

One more time....

Yes, the drug could be synergistic to Blarcamesine.

There is a long track record here...


Rockefeller medicine men : medicine and capitalism in America
by Brown, E. Richard

Publication date 1979
Topics Rockefeller Foundation, Carnegie Foundation for the Advancement of Teaching, Medicine -- United States History 20th century, Medical policy -- Business community participation United States History 20th century, Charities, Medical -- United States History 20th century, Medical economics -- United States History 20th century, Medical education -- United States History 20th century, United States -- Economic conditions 1865-1918
Publisher Berkeley : University of California Press
Collection americana
Digitizing sponsor Internet Archive
Contributor Internet Archive
Language English




https://archive.org/details/rockefellermedic00browrich/mode/1up